EN | UA
EN | UA

Help Support

Back

Hyaluronic acid supplement relieves pain and targets key OA biomarker

Joint health Joint health
Joint health Joint health

What's new?

Hyaluronan or Hyaluronic acid protects the cartilage, promotes joint health and modulates adropin levels, thereby managing inflammation and pain associated with knee osteoarthritis.

Renowned journal 'Cureus’ has published a new comparative trial addressing the effectiveness of popular supplements like hyaluronic acid (HA), glucosamine (Glc), and chondroitin sulfate (CS) for knee osteoarthritis (OA), a painful inflammatory condition.

Piercarlo Minoretti and colleagues enrolled 51 patients with mild-to-moderate knee OA for a four-week randomized, single-blind trial. Participants were divided into three groups consisting of 17 people in each group:

  • HA group (HA 300mg + Boswellia serrata extract) with one tablet given daily
  • Glc+CS group (Glc 415 mg + CS group 400 mg + curcuminoids isolated from Curcuma longa L 50 mg
  • Control group

Pain, function and serum adropin levels were assessed at the start and end of the study. Western Ontario and McMaster University Osteoarthritis Index (WOMAC) scores were used to evaluate OA. 

Both HA and Glc + CS supplements improved pain and function compared to baseline, with HA showing significantly better outcomes in pain relief and increased serum adropin levels. Both supplements were well-tolerated, with minimal adverse effects.

Source:

Cureus

Article:

Efficacy and Safety of Two Chondroprotective Supplements in Patients with Knee Osteoarthritis: A Randomized, Single-Blind, Pilot Study

Authors:

Piercarlo Minoretti et. al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: